| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Santhera Pharmaceuticals Holding AG (SW: SANN)
SANN Technical Analysis
4
| As on 9th Jun 2023 SANN STOCK Price closed @ 0.94 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1.07 & Strong Sell for SHORT-TERM with Stoploss of 1.40 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SANNSTOCK Price
| Open | 0.93 | Change | Price | % |
| High | 0.95 | 1 Day | 0.00 | 0.00 |
| Low | 0.93 | 1 Week | 0.09 | 10.59 |
| Close | 0.94 | 1 Month | 0.27 | 40.30 |
| Volume | 214486 | 1 Year | -0.36 | -27.69 |
| 52 Week High 1.62 | 52 Week Low 0.50 | ||||
SW Switzerland Most Active Stocks
| CSGN | 0.81 | 0.00% |
| CSGN | 0.81 | 0.00% |
| MBTN | 0.58 | 1.75% |
| ABBN | 34.50 | 0.76% |
| ABBN | 34.50 | 0.76% |
| UBSG | 18.20 | -0.27% |
| UBSG | 18.20 | -0.27% |
| NOVN | 90.17 | -0.22% |
| NOVN | 90.17 | -0.22% |
| NESN | 107.16 | 0.15% |
SW Switzerland Top Gainers Stocks
SW Switzerland Top Losers Stocks
| SANN Daily Charts |
SANN Intraday Charts |
Whats New @ Bazaartrend |
SANN Free Analysis |
|
|
SANN Important Levels Intraday
| RESISTANCE | 0.98 |
| RESISTANCE | 0.97 |
| RESISTANCE | 0.96 |
| RESISTANCE | 0.95 |
| SUPPORT | 0.93 |
| SUPPORT | 0.92 |
| SUPPORT | 0.91 |
| SUPPORT | 0.90 |
SANN Forecast April 2024
| 4th UP Forecast | 1.71 |
| 3rd UP Forecast | 1.46 |
| 2nd UP Forecast | 1.31 |
| 1st UP Forecast | 1.16 |
| 1st DOWN Forecast | 0.72 |
| 2nd DOWN Forecast | 0.57 |
| 3rd DOWN Forecast | 0.42 |
| 4th DOWN Forecast | 0.17 |
SANN Weekly Forecast
| 4th UP Forecast | 1.09 |
| 3rd UP Forecast | 1.04 |
| 2nd UP Forecast | 1.01 |
| 1st UP Forecast | 0.98 |
| 1st DOWN Forecast | 0.90 |
| 2nd DOWN Forecast | 0.87 |
| 3rd DOWN Forecast | 0.84 |
| 4th DOWN Forecast | 0.79 |
SANN Forecast2024
| 4th UP Forecast | 3.77 |
| 3rd UP Forecast | 2.86 |
| 2nd UP Forecast | 2.3 |
| 1st UP Forecast | 1.74 |
| 1st DOWN Forecast | 0.14 |
| 2nd DOWN Forecast | -0.42 |
| 3rd DOWN Forecast | -0.98 |
| 4th DOWN Forecast | -1.89 |
Santhera Pharmaceuticals Holding AG ( SW Switzerland Symbol : SANN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SANN Business Profile
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. It is developing Duchenne muscular dystrophy (DMD) product portfolio to treat patients irrespective of causative mutations, disease stage, or age. The company's late stage drug candidate include vamorolone, which is being developed as treatments for DMD. Its clinical stage pipeline also comprises lonodelestat (POL6014) to treat cystic fibrosis and other neutrophilic pulmonary diseases, as well as omigapil and an exploratory gene therapy approach targeting congenital muscular dystrophies. The company also out-licenses ex-North American rights to its approved product, Raxone (idebenone), for the treatment of Leber's hereditary optic neuropathy. It has collaboration agreement with Cold Spring Harbor Laboratory to investigate the potential of lonodelestat (POL6014), a potent inhibitor of human neutrophil elastase, as a therapeutic intervention for COVID-19-related acute respiratory distress syndrome. Santhera Pharmaceuticals Holding AG is headquartered in Pratteln, Switzerland. Address: Hohenrainstrasse 24, Pratteln, Switzerland, 4133
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service